Roxana Mehran, M.D., FACC, FACP, FCCP, FESC, FAHA, FSCAI, professor of medicine and director of interventional ...
TCT
This channel contains news about the annual Transcatheter Cardiovascular Therapeutics (TCT) conference presented by the Cardiovascular Research Foundation (CRF). It includes coverage from the annual meeting and links CRF news. TCT is the premier conference for the subspecialty of interventional cardiology, including the new subspecialty areas of transcatheter structural heart procedures.
October 10, 2019 — Here are the Cardiovascular Research Foundation (CRF) 12 late-breaking trials and 16 late-breaking ...
Torsten Vahl, M.D., director of experimental and translational research, Structural Heart and Valve Center and at the ...
The optimal delivery of cardiac care is evolving rapidly. A growing number of patients combined with innovative new ...
American Heart Association President Robert Harrington, M.D., interventional cardiologist and the Arthur L. Bloomfield ...
Chandan Devireddy, M.D., offers insights about what he saw as the top take aways from the 2019 Transcatheter ...
October 4, 2019 – A new analysis of the PARTNER 3 Trial data found a modest, but significant, improvement in one-year ...
October 4, 2019 – Results of a new economic analysis of the COAPT Trial data found that transcatheter mitral valve ...
October 4, 2019 – RenalGuard Therapy was found to be superior to the POSEIDON method in preventing contrast-induced ...
October 3, 2019 – Five-year results from the PARTNER 2A Trial found patients with severe aortic stenosis (AS) and ...
October 3, 2019 – Five-year data from the EXCEL Trial showed patients with left main coronary disease treated with ...
October 3, 2019 – The three-year results from the COAPT Trial demonstrated that reducing severe secondary mitral ...
October 2, 2019 – The first randomized trial to compare the safety and efficacy of the new Boston Scientific Acurate neo ...
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...
September 30, 2019 – The first randomized trial to compare a durable polymer drug-eluting stent to a polymer-free drug ...
September 30, 2019 — A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual ...